http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010096125-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2658d45a8e9c71b9598e2bf83242bab3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9488fce368b13af2df3f1626af1a9ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ad6fca509ff1483331d5f910a48b259 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1754 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2009-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60b450c149a897744b27519a2da2da17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b588ef71cb931a11a587b80a45789e12 |
| publicationDate | 2010-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2010096125-A1 |
| titleOfInvention | Methods and kits for treating disease by administering insulin-like growth factor binding protein-2 |
| abstract | The present invention is directed to methods of treating Type I diabetes by administering a therapeutically effective amount of an Insulin-like Growth Factor- binding protein-2. The present invention is also directed to methods treating Type 2 diabetes comprising the step of administering a therapeutically effective amount of Insulin-like Growth Factor-binding protein-2. The present invention is further directed to methods treating insulin resistance comprising the step of administering a therapeutically effective amount of Insulin-like Growth Factor-binding protein-2. The present invention is directed to methods of treating hepatic steatosis by administering a therapeutically effective amount of an Insulin-like Growth Factor-binding protein-2. The present invention is also directed to methods lowering blood glucose and serum insulin in non-diabetic subjects comprising the step of administering a therapeutically effective amount of Insulin-like Growth Factor-binding protein-2. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11192932-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019224786-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10947285-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8404639-B2 |
| priorityDate | 2008-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.